Eslicarbazepine Acetate Tablet
Product Images NDC 13668-538

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Eslicarbazepine Acetate (NDC 13668-538). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (03b79e36 491c 4aad 9dbe 5a59b6c06e30 001)

A table showing body weight ranges and corresponding initial and maximum titration increment dosages (mg/day) alongside maintenance dosages (mg/day) for Eslicarbazepine acetate tablets. Dosages are organized to guide dosage adjustments based on patient body weight.*

FDA Label Image

Image Description (03b79e36 491c 4aad 9dbe 5a59b6c06e30 002)

Chemical structure of Eslicarbazepine acetate showing its molecular framework with fused rings and functional groups, including ester and amide moieties.*

FDA Label Image

Image Description (03b79e36 491c 4aad 9dbe 5a59b6c06e30 003)

A forest plot chart illustrating fold change and 90% confidence intervals for eslicarbazepine acetate pharmacokinetics related to demographic and clinical factors. The chart shows effect of age, gender, hepatic impairment (mild, moderate, severe), and renal impairment (mild, moderate, severe) on drug exposure with corresponding dosing recommendations.*

FDA Label Image

Image Description (03b79e36 491c 4aad 9dbe 5a59b6c06e30 004)

A scatter plot chart showing fold changes with 90% confidence intervals for various anticonvulsant drugs relative to eslicarbazepine acetate, including Carbamazepine, Gabapentin, Lamotrigine, Levetiracetam, Phenobarbital, Phenytoin, Topiramate, and Valproate. Recommendations regarding dose adjustments for certain drugs are noted alongside the chart.*

FDA Label Image

Image Description (03b79e36 491c 4aad 9dbe 5a59b6c06e30 005)

A horizontal error bar chart depicting fold changes and 90% confidence intervals for various drugs when administered with respect to a reference. The chart shows changes for Carbamazepine, Gabapentin, Lamotrigine, Levetiracetam, Phenobarbital, Phenytoin, Topiramate, and Valproate, with corresponding recommendations regarding dose adjustments or monitoring for pharmacodynamic interactions.*

FDA Label Image

Image Description (03b79e36 491c 4aad 9dbe 5a59b6c06e30 007)

A Kaplan-Meier estimate chart showing exit rates with 95% confidence intervals for Eslicarbazepine acetate tablets at 1,200 mg and 1,600 mg dosages. Data points represent two studies and historical controls, with sample sizes indicated for each study group.*

FDA Label Image

Image Description (03b79e36 491c 4aad 9dbe 5a59b6c06e30 008)

A bar chart showing the proportion of patients by percentage reduction in seizure frequency from baseline. It compares placebo with Eslicarbazepine acetate tablets at 800 mg and 1,200 mg doses across five categories: Worse, 0 to less than 25%, 25 to less than 50%, 50 to less than 75%, and 75 to 100% reduction.*

FDA Label Image

Image Description (03b79e36 491c 4aad 9dbe 5a59b6c06e30 009)

FDA Label Image

Image Description (03b79e36 491c 4aad 9dbe 5a59b6c06e30 010)

FDA Label Image

Image Description (03b79e36 491c 4aad 9dbe 5a59b6c06e30 06)

A chart depicting fold change and 90% confidence intervals for the interaction effects of Eslicarbazepine acetate on various other drugs, including digoxin, metformin, statins (simvastatin, rosuvastatin), oral contraceptives (ethinylestradiol, levonorgestrel), and warfarin (S-warfarin, R-warfarin). It includes recommendations for dose adjustments or monitoring based on drug interaction observations.*

FDA Label Image

200mg (200mg 30 Tablets)

Label for Eslicarbazepine Acetate Tablets 200 mg by Torrent Pharmaceuticals Limited. The label includes dosing instructions indicating the medication is to be taken once daily. It shows a quantity of 30 tablets with NDC 13668-538-30 and storage instructions to keep tightly closed and store at controlled room temperature. The label contains warnings to keep out of reach of children and dispenser instructions for pharmacists.*

FDA Label Image

400mg (400mg 30 Tablets)

Label for Eslicarbazepine Acetate Tablets 400 mg by Torrent Pharmaceuticals Limited, containing 30 oral tablets. The label includes storage instructions, dosage guidance to see accompanying prescribing information, and a caution to keep out of reach of children. It also specifies dispensing with a child-resistant closure and indicates prescription-only status.*

FDA Label Image

600mg (600mg 30 Tablets)

Label for Eslicarbazepine Acetate Tablets 600 mg by Torrent Pharmaceuticals Limited. The label indicates that the package contains 30 tablets for oral use. It includes storage instructions, dosage form, strength, dispensing information, and a barcode. The label states 'Rx only' and provides manufacturer details.*

FDA Label Image

800mg (800mg 30 Tablets)

Label for Eslicarbazepine Acetate Tablets, 800 mg strength, oral dosage form, in a package of 30 tablets. The label includes storage instructions, dosage advisory to see prescribing information, and directions for pharmacists to dispense the medication guide. Manufactured by Torrent Pharmaceuticals Limited, India, for Torrent Pharma Inc., USA. The label features a barcode and an NDC number 13668-541-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.